Linked Life Data

15275046

Source:http://linkedlifedata.com/resource/pubmed/id/15275046

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15275046rdf:typepubmed:Citationlld:pubmed
pubmed-article:15275046lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:15275046lifeskim:mentionsumls-concept:C0020966lld:lifeskim
pubmed-article:15275046lifeskim:mentionsumls-concept:C0041221lld:lifeskim
pubmed-article:15275046lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:15275046pubmed:issue9lld:pubmed
pubmed-article:15275046pubmed:dateCreated2004-7-27lld:pubmed
pubmed-article:15275046pubmed:abstractTextInfection of humans with the protozoan Trypanosoma cruzi leads to Chagas disease, or American trypanosomiasis, a disease that affects nearly 20 million people, and constitutes one of the largest socioeconomic burdens in Latin America. Much of the present knowledge on pathogenic mechanisms underlying T. cruzi infection comes from experimental murine models. Here, George A. DosReis reviews recent findings about the features of host cell-mediated immunity against the parasite and possible mechanisms leading to chronic infection.lld:pubmed
pubmed-article:15275046pubmed:languageenglld:pubmed
pubmed-article:15275046pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15275046pubmed:statusPubMed-not-MEDLINElld:pubmed
pubmed-article:15275046pubmed:monthSeplld:pubmed
pubmed-article:15275046pubmed:issn0169-4758lld:pubmed
pubmed-article:15275046pubmed:authorpubmed-author:DosReisG AGAlld:pubmed
pubmed-article:15275046pubmed:issnTypePrintlld:pubmed
pubmed-article:15275046pubmed:volume13lld:pubmed
pubmed-article:15275046pubmed:ownerNLMlld:pubmed
pubmed-article:15275046pubmed:authorsCompleteYlld:pubmed
pubmed-article:15275046pubmed:pagination335-42lld:pubmed
pubmed-article:15275046pubmed:year1997lld:pubmed
pubmed-article:15275046pubmed:articleTitleCell-mediated immunity in experimental Trypanosoma cruzi infection.lld:pubmed
pubmed-article:15275046pubmed:affiliationImmunobiology Program, Instituto de Biofisica Carlos Chagas Filho da Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Ilha do Fundão, Rio de Janeiro, RJ 21944-970, Brazil.lld:pubmed
pubmed-article:15275046pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15275046lld:pubmed